• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于症状的算法,用于对有高风险暴露史的成人COVID-19进行快速临床诊断。

A Symptom-Based Algorithm for Rapid Clinical Diagnosis of COVID-19 in Adults With High-Risk Exposure.

作者信息

Inaba Shinji, Ikeda Shuntaro, Tsuda Naoki, Sogabe Kyosei, Inoue Katsuji, Nogami Naoyuki, Ishii Eiichi, Yamaguchi Osamu

机构信息

Department of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Toon, JPN.

Department of Community Medicine, Pulmonology, and Cardiology, Ehime University Graduate School of Medicine, Toon, JPN.

出版信息

Cureus. 2025 Aug 7;17(8):e89589. doi: 10.7759/cureus.89589. eCollection 2025 Aug.

DOI:10.7759/cureus.89589
PMID:40926953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12414847/
Abstract

Objectives In Japan, clinical diagnosis based solely on symptoms, without the use of test kits, has been adopted to enable the rapid identification of individuals infected with coronavirus disease 2019 (COVID-19). A history of close contact with COVID-19 patients is a prerequisite for such symptom-based diagnosis. However, the current diagnostic criteria lack objectivity. This study aimed to develop a symptom-based algorithm stratified by vaccination status to support more reliable clinical diagnosis of COVID-19 among individuals with high-risk exposure. Methods This retrospective, single-center study was conducted in Japan between April 2021 and May 2022. An algorithm for predicting COVID-19 infection was developed by comparing symptoms in COVID-19-positive and COVID-19-negative individuals with high-risk exposure. Analyses were stratified by vaccination status, given its potential influence on symptom presentation. Patients A total of 179 individuals with high-risk exposure to COVID-19 patients were included in the analysis. Results The most common setting of close contact was within households or among roommates (55.3%, 99/179), followed by workplace or school settings (26.3%, 47/179). The combination of all three symptoms-fever, sore throat, and cough-demonstrated 100% specificity but low sensitivity, irrespective of vaccination status. Among vaccinated individuals, the combination of sore throat and cough was a more reliable diagnostic indicator, whereas fever was more predictive among unvaccinated individuals. Conclusion The symptom-based diagnostic algorithm developed in this study demonstrated a sensitivity of 65.3% and a specificity of 88.5%, approaching the diagnostic performance of rapid antigen testing. This algorithm may facilitate simple, rapid, and accessible clinical diagnosis of COVID-19 in resource-limited or high-demand settings.

摘要

目的 在日本,已采用仅基于症状而不使用检测试剂盒的临床诊断方法,以快速识别感染2019冠状病毒病(COVID-19)的个体。与COVID-19患者的密切接触史是这种基于症状诊断的前提条件。然而,目前的诊断标准缺乏客观性。本研究旨在开发一种按疫苗接种状况分层的基于症状的算法,以支持对高风险暴露个体进行更可靠的COVID-19临床诊断。方法 这项回顾性单中心研究于2021年4月至2022年5月在日本进行。通过比较高风险暴露的COVID-19阳性和COVID-19阴性个体的症状,开发了一种预测COVID-19感染的算法。鉴于疫苗接种状况对症状表现的潜在影响,分析按疫苗接种状况进行分层。患者 共有179名高风险暴露于COVID-19患者的个体纳入分析。结果 最常见的密切接触场景是在家庭内部或室友之间(55.3%,99/179),其次是工作场所或学校环境(26.3%,47/179)。无论疫苗接种状况如何,发热、喉咙痛和咳嗽这三种症状同时出现时特异性为100%,但敏感性较低。在接种疫苗的个体中,喉咙痛和咳嗽同时出现是更可靠的诊断指标,而在未接种疫苗的个体中发热的预测性更强。结论 本研究开发的基于症状的诊断算法敏感性为65.3%,特异性为88.5%,接近快速抗原检测的诊断性能。该算法可能有助于在资源有限或需求高的环境中对COVID-19进行简单、快速且可及的临床诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/ee58fd9b6760/cureus-0017-00000089589-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/6b36def80c50/cureus-0017-00000089589-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/9598bf98523c/cureus-0017-00000089589-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/ee58fd9b6760/cureus-0017-00000089589-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/6b36def80c50/cureus-0017-00000089589-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/9598bf98523c/cureus-0017-00000089589-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72a6/12414847/ee58fd9b6760/cureus-0017-00000089589-i03.jpg

相似文献

1
A Symptom-Based Algorithm for Rapid Clinical Diagnosis of COVID-19 in Adults With High-Risk Exposure.一种基于症状的算法,用于对有高风险暴露史的成人COVID-19进行快速临床诊断。
Cureus. 2025 Aug 7;17(8):e89589. doi: 10.7759/cureus.89589. eCollection 2025 Aug.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.症状和胸部 X 线筛查在 HIV 阴性的成年人和 HIV 状态未知的成年人中的活动性肺结核。
Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2.
8
Delayed antibiotic prescriptions for respiratory infections.呼吸道感染的延迟抗生素处方
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD004417. doi: 10.1002/14651858.CD004417.pub5.
9
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement.关于长新冠患者评估与治疗的多学科协作指南:一份概要声明
PM R. 2025 Apr 22. doi: 10.1002/pmrj.13397.
10
Immediate versus delayed versus no antibiotics for respiratory infections.即刻与延迟用与不用抗生素治疗呼吸道感染。
Cochrane Database Syst Rev. 2023 Oct 4;10(10):CD004417. doi: 10.1002/14651858.CD004417.pub6.

本文引用的文献

1
Diagnosis of COVID-19: Is Fever the Best Indicator of COVID-19 in Vaccinated SARS-CoV-2-Positive Adults?2019冠状病毒病的诊断:发热是接种新冠病毒疫苗的新冠病毒检测呈阳性成年人中2019冠状病毒病的最佳指标吗?
Cureus. 2024 Sep 5;16(9):e68749. doi: 10.7759/cureus.68749. eCollection 2024 Sep.
2
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.重复接种疫苗诱导产生的IgG4抗体可能会对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白产生免疫耐受。
Vaccines (Basel). 2023 May 17;11(5):991. doi: 10.3390/vaccines11050991.
3
Simple Symptom-Based Prediction of COVID-19: A Single-Center Study of Outpatient Fever Clinic in Japan.
基于简单症状的新型冠状病毒肺炎预测:日本一家门诊发热诊所的单中心研究
Cureus. 2023 Mar 24;15(3):e36614. doi: 10.7759/cureus.36614. eCollection 2023 Mar.
4
Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management.COVID-19 疫苗接种后的抗体依赖疾病增强(ADE)和β葡聚糖作为更安全的管理策略。
Vaccine. 2023 Apr 6;41(15):2427-2429. doi: 10.1016/j.vaccine.2023.03.005. Epub 2023 Mar 8.
5
Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant.比较奥密克戎变异株出现前后医护人员新冠肺炎(COVID-19)症状的诊断差异。
Infect Control Hosp Epidemiol. 2023 May;44(5):821-823. doi: 10.1017/ice.2022.105. Epub 2022 May 4.
6
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.家庭环境中 SARS-CoV-2 变异株的二次感染率及其与疫苗接种状态的关系:一项更新的系统评价和荟萃分析。
JAMA Netw Open. 2022 Apr 1;5(4):e229317. doi: 10.1001/jamanetworkopen.2022.9317.
7
Comparison of the clinical parameters of patients with COVID-19 and influenza using blood test data: a retrospective cross-sectional survey.利用血液检测数据比较 COVID-19 和流感患者的临床参数:一项回顾性横断面调查。
J Int Med Res. 2022 Feb;50(2):3000605221083751. doi: 10.1177/03000605221083751.
8
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance.奥密克戎变异株(B.1.1.529):传染性、疫苗突破和抗体耐药性。
J Chem Inf Model. 2022 Jan 24;62(2):412-422. doi: 10.1021/acs.jcim.1c01451. Epub 2022 Jan 6.
9
Predictors of COVID-19 in an outpatient fever clinic.门诊发热诊所中新冠病毒病的预测因素
PLoS One. 2021 Jul 21;16(7):e0254990. doi: 10.1371/journal.pone.0254990. eCollection 2021.
10
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.BNT162b2 和 mRNA-1273 疫苗对新冠病毒的预防和衰减作用。
N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30.